Sunday, December 2, 2018

Sun Pharma plunges 10% as SEBI plans to reopen insider trading case

Sun Pharma plunges 10% as SEBI plans to reopen insider trading case Sun Pharma, along with its Managing Director Dilip Shanghvi, and nine others had settled the insider trading probe, paying Rs 18 lakh against the settlement charges in 2017

from Moneycontrol Business News https://ift.tt/2Q9ybrR

No comments:

Post a Comment

Apollo Micro Systems shares surge 15% following Rs 25 cr order wins from DRDO, other defence PSUs

Apollo Micro Systems shares saw a significant rise. The company secured orders worth Rs 25.12 crores from DRDO and Defence PSUs. This news b...